Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06904638

Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)

Status
Recruiting
Phase
Study type
Observational
Enrollment
374 (estimated)
Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.

Detailed description

Polypharmacy in older patients is associated with both inappropriate drug prescribing and underprescription or omission of appropriate medications. Potential prescriptive omission (PPO), defined as the underprescription of potentially beneficial drugs, is increasing across all care settings and is associated with adverse clinical outcomes. However, in some cases, PPO may represent a legitimate medical decision. The aim of this study is to investigate the phenomenon of underprescription by differentiating between justified and inappropriate potential prescriptive omissions (PPOs) in elderly patients in both hospital and outpatient settings, using the Screening Tool to Alert to Right Treatment (START) criteria, version 3.

Conditions

Timeline

Start date
2024-06-20
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-04-01
Last updated
2025-04-01

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06904638. Inclusion in this directory is not an endorsement.